Page last updated: 2024-09-05

tolvaptan and dinoprostone

tolvaptan has been researched along with dinoprostone in 2 studies

Compound Research Comparison

Studies (tolvaptan)	Trials (tolvaptan)	Recent Studies (post-2010) (tolvaptan)	Studies (dinoprostone)	Trials (dinoprostone)	Recent Studies (post-2010) (dinoprostone)
967	172	786	29,105	1,346	6,357

Protein Interaction Comparison

Protein	Taxonomy	dinoprostone (IC50)
Prostaglandin E2 receptor EP1 subtype	Homo sapiens (human)	0.0155
Prostaglandin E2 receptor EP4 subtype	Homo sapiens (human)	0.0031
Prostaglandin E2 receptor EP4 subtype	Rattus norvegicus (Norway rat)	0.0021
Prostaglandin E2 receptor EP3 subtype	Homo sapiens (human)	0.002
Prostaglandin E2 receptor EP2 subtype	Homo sapiens (human)	0.0087
Prostacyclin receptor	Homo sapiens (human)	0.26
Prostaglandin E2 receptor EP2 subtype	Rattus norvegicus (Norway rat)	0.0052

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Bankir, L; Bichet, DG; Guerrot, D	1
Fenton, RA; Gansevoort, RT; Geurts, F; Hoorn, EJ; Kramers, BJ; Meijer, E; Salih, M; Xue, L; Zietse, R	1

Other Studies

2 other study(ies) available for tolvaptan and dinoprostone

Article	Year
Vaptans or voluntary increased hydration to protect the kidney: how do they compare? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023, 02-28, Volume: 38, Issue:3 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Dinoprostone; Humans; Kidney; Kidney Medulla; Receptors, Vasopressin; Sodium; Tolvaptan	2023
Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical journal of the American Society of Nephrology : CJASN, 2023, 11-01, Volume: 18, Issue:11 Topics: Antidiuretic Hormone Receptor Antagonists; Dinoprostone; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Kidney; Male; Osmoregulation; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Renal Insufficiency; Tolvaptan	2023

Article

Year

Vaptans or voluntary increased hydration to protect the kidney: how do they compare?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023, 02-28, Volume: 38, Issue:3

Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Dinoprostone; Humans; Kidney; Kidney Medulla; Receptors, Vasopressin; Sodium; Tolvaptan

2023

Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Clinical journal of the American Society of Nephrology : CJASN, 2023, 11-01, Volume: 18, Issue:11

Topics: Antidiuretic Hormone Receptor Antagonists; Dinoprostone; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Kidney; Male; Osmoregulation; Polycystic Kidney, Autosomal Dominant; Prospective Studies; Renal Insufficiency; Tolvaptan

2023